September 12, 2023 Comments Off on New patent for Abbvie drug UBRELVY Posted in: Patent Added Annual Drug Patent Expirations for UBRELVY Ubrelvy is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Abbvie drug UBRELVY appeared first on DrugPatentWa…
September 12, 2023 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared f…